Open Access
CC BY 4.0 · Indian Journal of Neurotrauma
DOI: 10.1055/s-0045-1810103
Letter to the Editor

Voice of the Future: Neurointerfaces for Amyotrophic Lateral Sclerosis Communication

Abeera Saleem Mughal
1   Department of Internal Medicine, Jinnah Sindh Medical University, Karachi, Pakistan
,
2   Department of Internal Medicine, King Edward Medical University, Lahore, Pakistan
› Author Affiliations

Funding None.
 

Amyotrophic lateral sclerosis (ALS) is a degenerative neurological condition that causes muscle weakness. In advanced stages, it progresses to tetraplegia accompanied by loss of speech and inability to communicate.[1] Brain–computer interfaces (BCIs) can help individuals with ALS by restoring their ability to speak. Such devices work by decoding intracortical brain signals into intended speech.

For this, in 2024, a clinical demonstration was conducted in which a 45-year-old man with advanced-stage ALS and severe dysarthria was surgically implanted with four microelectrode arrays. Just 25 days later, this system showed promising results. On the first day, testing showed that the system achieved 99.6% accuracy with a limited vocabulary and 90.2% on the second day with a much larger vocabulary. This shows that with little training, a patient will be able to communicate like other normal people.[2]

However, these text-based BCIs miss important aspects of human speech, such as tone, rhythm, and the inability to hear one's voice simultaneously. For this, in 2025, scientists implanted 256 microelectrodes in the ventral precentral gyrus of a man with ALS who can no longer speak. This system could instantly decode his neural activity, generating speech sounds while also giving real-time audio feedback identical to his voice. Even though we had no clear sample of his true speech, researchers succeeded in not only decoding exact phonemes but also paralinguistic features, including emotions, tone, and even melodies. This groundbreaking discovery can enable such ALS patients to express themselves with their natural speech and emotions.[3]

BCIs also pose certain ethical challenges. These include users' autonomy, privacy, and responsibility. This raises concerns about user control, sensitive brain data, and a lack of accountability. Such ethical implications can be overcome by introducing varying levels of user control.[4] While most research focuses on training BCI systems to interpret brain signals better, a key question remains: can users also learn to control their brain activity to improve BCI performance? For this, in a recent study, 15 healthy people were taught how to use a BCI system that reads EEG signals. Participants had to imagine syllables daily for 5 consecutive days. Over time, they got better at using BCI, but at different paces. A control experiment was also run, and found that giving participants real-time feedback on how well they are doing is very crucial. People only improved when they knew how the system was responding to their brain signals. As they improved, visible changes were seen in their brain waves. Theta activity increased in their frontal, and gamma activity decreased in their temporal part of the brain.[5]

Another overlooked aspect is the underreported user experience. Knowing how the user feels using BCI devices from soon after surgery to long-term use can help develop better systems. Even though recent advancements in BCI suggest a promising future, such devices are still quite costly, which can exclude patients, leading to unfair gaps and widening societal inequality.[6]

To conclude, there is no doubt that ongoing breakthroughs in neurotechnology hold potential for significant impact. But to make real-world change, we need continued research, user-friendly designs, and attention toward ethical challenges. Urgent investment is required to scale these solutions and ensure equitable access to every patient in need, regardless of their background or income.


Conflict of Interest

None declared.


Address for correspondence

Muhammad Talha, MBBS
King Edward Medical University
Lahore 54000
Pakistan   

Publication History

Article published online:
09 August 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India